Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Cell Communication and Signaling : CCS
|
February 10, 2025
A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling
Ylenia Ferrara, Debora Latino, Angela Costagliola di Polidoro, et al.
Journal of Medicinal Chemistry
|
May 5, 2017
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier
Ilaria Monaco, Simona Camorani, David Colecchia, et al.
Scientific Reports
|
April 30, 2016
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells
Michela Vitiello, Teresa Valentino, Marta De Menna, et al.
Theranostics
|
November 16, 2018
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
Simona Camorani, Billy Samuel Hill, Francesca Collina, et al.
Cancers
|
March 28, 2018
Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene
Mario Monaco, Giuseppe Palma, Michela Vitiello, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 27, 2024
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
Simona Camorani, Alessandra Caliendo, Elena Morrone, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 23, 2021
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
Lisa Agnello, Silvia Tortorella, Annachiara d'Argenio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 21, 2014
Multifunctional aptamer-miRNA conjugates for targeted cancer therapy
Carla L Esposito, Laura Cerchia, Silvia Catuogno, et al.
Oncology
|
January 22, 2010
Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors
Luigi Insabato, Ivano Amelio, Maria Quarto, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 7, 2020
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Simona Camorani, Margherita Passariello, Lisa Agnello, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Cell Communication and Signaling : CCS
|
February 10, 2025
A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling
Ylenia Ferrara, Debora Latino, Angela Costagliola di Polidoro, et al.
Journal of Medicinal Chemistry
|
May 5, 2017
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier
Ilaria Monaco, Simona Camorani, David Colecchia, et al.
Scientific Reports
|
April 30, 2016
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells
Michela Vitiello, Teresa Valentino, Marta De Menna, et al.
Theranostics
|
November 16, 2018
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
Simona Camorani, Billy Samuel Hill, Francesca Collina, et al.
Cancers
|
March 28, 2018
Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene
Mario Monaco, Giuseppe Palma, Michela Vitiello, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 27, 2024
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
Simona Camorani, Alessandra Caliendo, Elena Morrone, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 23, 2021
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
Lisa Agnello, Silvia Tortorella, Annachiara d'Argenio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 21, 2014
Multifunctional aptamer-miRNA conjugates for targeted cancer therapy
Carla L Esposito, Laura Cerchia, Silvia Catuogno, et al.
Oncology
|
January 22, 2010
Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors
Luigi Insabato, Ivano Amelio, Maria Quarto, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 7, 2020
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Simona Camorani, Margherita Passariello, Lisa Agnello, et al.
Page
of 8